Table 1 Frequent regions affected by cnLOH in SCRC cases: (A) Four SCRC groups and (B) Two SCRC groups.

From: Copy neutral loss of heterozygosity (cnLOH) patterns in synchronous colorectal cancer

(A)

Chromosome

Cytoband start

Cytoband end

SCRC

MM SCRC

MP SCRC

PM SCRC

PP SCRC

p valuea

16

p11.2

p11.1

44 (59.5)

10 (62.5)

12 (75.0)

12 (50.0)

10 (55.6)

NS

11

p11.2

p11.12

21 (28.4)

5 (31.3)

3 (18.8)

5 (20.8)

8 (44.4)

NS

2

q11.1

q11.2

11 (14.9)

1 (6.3)

3 (18.8)

2 (8.3)

5 (27.8)

NS

10

q22.1

q22.2

11 (14.9)

4 (25.0)

1 (6.3)

4 (16.7)

2 (11.1)

NS

8

q11.1

q23.3

10 (13.5)

2 (12.5)

5 (31.3)

3 (12.5)

NS

6

p22.1

p21.32

9 (12.2)

1 (6.25)

6 (25.0)

2 (11.1)

NS

7

q11.21

q11.22

9 (12.2)

4 (25.0)

3 (12.5)

2 (11.1)

NS

4

q24

q35.2

7 (9.5)

2 (12.5)

3 (12.5)

2 (11.1)

NS

5

q34

q35.3

7 (9.5)

1 (6.3)

3 (18.8)

2 (8.3)

1 (5.6)

NS

8

p23.1

p11.1

7 (9.5)

2 (15.5)

3 (18.8)

2 (8.3)

NS

10

p12.31

p12.1

7 (9.5)

2 (12.5)

3 (18.8)

1 (4.2)

1 (5.6)

NS

(B)

Chromosome

Cytoband start

Cytoband end

SCRC

Monoclonal

Polyclonal

p valuea

  

16

p11.2

p11.1

44 (59.5)

22 (68.8)

22 (52.4)

NS

  

11

p11.2

p11.12

21 (28.4)

8 (25.0)

13 (31.0)

NS

  

2

q11.1

q11.2

11 (14.9)

4 (12.5)

7 (16.7)

NS

  

10

q22.1

q22.2

11 (14.9)

5 (15.6)

6 (14.3)

NS

  

8

q11.1

q23.3

10 (13.5)

7 (21.9)

3 (7.1)

NS

  

6

p22.1

p21.32

9 (12.2)

1 (3.1)

8 (19.0)

0.038

  

7

q11.21

q11.22

9 (12.2)

4 (12.5)

5 (11.9)

NS

  

4

q24

q35.2

7 (9.5)

2 (6.3)

5 (11.9)

NS

  

5

q34

q35.3

7 (9.5)

4 (12.5)

3 (7.1)

NS

  

8

p23.1

p11.1

7 (9.5)

5 (15.6)

2 (4.8)

NS

  

10

p12.31

p12.1

7 (9.5)

5 (15.6)

2 (4.8)

NS

  
  1. aStatistical analysis was performed by Pearson’s Chi square (χ2) test. Parentheses refer to percentage numbers. cnLOH copy-number-neutral loss of heterozygosity, SCRC synchronous colorectal cancer, MM monoclonal monosegmental, MP monoclonal pancolonic, PM polyclonal monosegmental, PP polyclonal pancolonic.